HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA: EOS Lip Balms Linked To Adverse Reactions, But Cause Is Unknown

This article was originally published in The Rose Sheet

Executive Summary

In a March 16 post to its website, FDA says that after inspecting EOS Products' contract manufacturer, it still cannot determine why consumers are experiencing rashes, blisters and cracked lips following use of EOS Lip Balm.


Related Content

FDA Divulges Cosmetics Enforcement Data, Notes Hair Loss As ‘Serious’ AE
PCPC: Cosmetic Legislation A Long Shot In 2016, But Objectives Are Clear
Complaints Allege Guthy-Renker’s WEN Conditioner Line Causes Hair Loss





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts